3billion

by 3billion  · Based in South Korea → — AI-powered genetic testing for rare disease diagnosis
Laboratory Medicine Neurology Pediatrics

Overview

3billion offers AI-powered genetic testing for rare disease diagnosis, providing services for clinicians and patients. The platform aims to assist in diagnosing patients who have spent years without a clear explanation for their symptoms, suggesting rare diseases as a potential answer.

  • What it does: 3billion provides genetic testing services including 3B-GENOME and 3B-EXOME, with results available within four weeks. It also offers GEBRA™ for converting VCF files to final reports. The technology incorporates AI tools such as EVIDENCE, which classifies whole exome sequencing (WES) variants, 3Cnet for predicting pathogenicity of variants lacking evidence, and 3ASC for ranking candidate variants by symptom similarity.
  • Who it is for: The services are intended for clinicians treating patients with suspected rare diseases.
  • How it fits a clinical or practice workflow: Clinicians can order genetic tests, receive sample kits, and obtain clear test reports. The platform also includes clinical consultation and continuous reanalysis of undiagnosed cases until a diagnosis is found. Clinicians can ask about results, request VUS reviews, or share new symptoms for reinterpretation.
  • Notable capabilities:
    • EVIDENCE: Classifies approximately 100,000 WES variants in an average of 5 minutes, adhering to ACMG criteria with 98.4% sensitivity and 99.99% specificity.
    • 3Cnet: AI predicts pathogenicity for variants lacking evidence, showing 2.2 times higher sensitivity and improving VUS reclassification.
    • 3ASC: Ranks candidate variants by symptom similarity, identifying the causative variant in the top 5 in 96% of cases.
    • Reanalysis: Undiagnosed cases are continuously reanalyzed.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered genetic testing
  • Variant analysis automation
  • Enhanced accuracy in genetic testing
  • Faster results (within 4 weeks for 3B-GENOME & 3B-EXOME)
  • EVIDENCE: Classifies ~100,000 WES variants in 5 minutes (98.4% sensitivity, 99.99% specificity)
  • 3Cnet: AI predicts pathogenicity for variants lacking evidence (2.2x higher sensitivity)
  • 3ASC: Ranks candidate variants by symptom similarity (causative variant in top 5 in 96% of cases)
  • Reanalysis of undiagnosed cases
  • Clinical consultation
  • Easy ordering with sample kit included

Use Cases

  • Rare disease diagnosis
  • Genetic variant interpretation
  • Reanalysis of undiagnosed genetic cases
  • Drug discovery

What Physicians Need to Know

Evidence Base
ACMG criteria for variant classification. AI predicts pathogenicity for variants lacking evidence. Ranks candidate variants by symptom similarity.
Clinical Validation Studies
98.4% sensitivity and 99.99% specificity for variant classification. Causative variant in the top 5 in 96% of cases when ranking by symptom similarity.
Differential Diagnosis Support
Ranks candidate variants by symptom similarity, with the causative variant in the top 5 in 96% of cases.
Clinical Workflow Integration
Offers reanalysis of undiagnosed cases, continuously revisiting data. Provides clinical consultation and VUS review.
Decision Audit Trail
A report with classification evidence and interpretation is provided.
Physician Tip

Leverage the reanalysis service for undiagnosed patients, as the platform continuously re-evaluates data with new evidence. Utilize the clinical genetics team for consultations, VUS reviews, and reinterpretation based on new symptoms.

The platform supports clinicians globally, with testing available in over 70 countries and used by over 2,200 clinicians. It also partners with global pharma for precision prescribing.

Details

Category Clinical Decision Support & Reference, Lab & Diagnostics
Pricing Unknown
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Unknown
Integrations
EHR Not specified
Specialties Laboratory Medicine, Neurology, Pediatrics

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate 3billion

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for 3billion.

Loading videos...

View all on YouTube

Frequently Asked Questions

3billion provides AI-powered genetic testing to assist physicians in diagnosing rare diseases in patients who have spent years without a clear explanation for their symptoms.
Physicians can order genetic tests, and 3billion provides a sample kit. The service then delivers a clear test report and offers clinical consultation.
3billion utilizes EVIDENCE for variant classification, 3Cnet for predicting pathogenicity of variants lacking evidence, and 3ASC for ranking candidate variants by symptom similarity.
3billion continuously reanalyzes data from undiagnosed patients until a diagnosis is found, revisiting data as new information becomes available.
Physicians can consult with 3billion's clinical genetics team to discuss results, request VUS reviews, or share new symptoms for reinterpretation.

Related Tools

GPnotebook
Oxbridge Solutions Limited
Clinical Decision Support & Reference
GPnotebook AI Answers provides quick, reliable, and extensive clinical information and educational resources for healthcare professionals, especially those in primary care.
LabSense AI
LabSense AI
Clinical Decision Support & Reference
LabSense AI is a free, no-signup online tool that explains lab results in plain English, checks against WHO/IFCC reference ranges, and flags critical values.
IMO Clinical AI
Intelligent Medical Objects (IMO)
Clinical Decision Support & Reference
IMO Clinical AI leverages natural language processing to transform unstructured clinical data into actionable insights for healthcare organizations.
Cloudphysician Smart-ICU
Cloudphysician
Clinical Decision Support & Reference
Cloudphysician provides AI-enabled virtual care infrastructure and expert intensivist-led care for ICUs, leveraging real-time patient data and AI-powered computer vision to improve patient outcomes and reduce staff workload.
Exo Iris
Exo Imaging, Inc.
Cardiology AI
Johns Hopkins ACG
Johns Hopkins Bloomberg School of Public Health
Clinical Decision Support & Reference
The Johns Hopkins ACG System is a software-based tool for categorizing diagnoses and medications to understand individual patients and populations, assessing and responding to health challenges.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-11-08
AI Tool Finder
AI-powered search. Results may not be comprehensive.